Enhanced magnetic hyperthermia using anti-PD-L1 antibody-conjugated magnetoliposomes in a murine subcutaneous bladder cancer model
Our αPD-L1@MCL enables hyperthermia with magnetic nanoparticles and immunotherapy with an anti-PD-L1 antibody. These findings support further development of hyperthermia mediated by anti-PD-L1 antibody-conjugated magnetic nanoparticles as a promising therapeutic strategy for BC.
Authors
- Masahiro Kaneko (ORCID: https://orcid.org/0000-0002-8309-4086)
- Rintaro Saito (ORCID: https://orcid.org/0000-0001-9084-8045)
- Nobuhiko Shimizu (ORCID: https://orcid.org/0000-0001-7280-2481)
- Masakazu Gonda (ORCID: https://orcid.org/0009-0002-9514-1561)
- Atsushi Okada
- T. Nagai
- T. Etani
- Maria Aoki
- Daiki Ishikawa (ORCID: https://orcid.org/0009-0007-7975-2983)
- Shuzo Hamamoto
- Akira Ito
- Takahiro Yasui
- Noriyasu Kawai
- Taku Naiki
- Toshiharu Morikawa
Institutions
- Nagoya City University (JP)
- Nagoya City University Hospital (JP)
- Sendai Kousei Hospital (JP)
- Nagoya University (JP)
Publication Details
- Journal
- International Journal of Hyperthermia
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1080/02656736.2026.2645413
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00